GYNECOLOGIC CANCER

Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.Read more....

Related Posts

GENITOURINARY CANCER—KIDNEY AND BLADDER

 17

A chemical biology/modular antibody platform for ADP-ri...

 15

GASTROINTESTINAL CANCER—COLORECTAL AND ANAL

 28